期刊
CRITICAL CARE MEDICINE
卷 44, 期 2, 页码 E97-E100出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/CCM.0000000000001389
关键词
blood glucose self-monitoring; Centers for Medicare and Medicaid Services (United States); diabetes mellitus; glucose; perioperative care; US Food and Drug Administration
资金
- Departments of Anesthesiology, Vanderbilt University School of Medicine
- Departments of Anesthesiology and Medicine, the University of Wisconsin School of Medicine and Public Health
- Diabetes Technology Society
- Roche Diabetes Care
- American Board of Anesthesiology
- Isomark, LLC
Objective: This special article will review the history of blood glucose meter hospital use and current issues surrounding their use in this patient population. Study Selection: Secondary to accuracy concerns that have been known, but likely underappreciated for many years, the U.S. Food and Drug Administration and Centers for Medicare and Medicaid Services are moving toward eliminating current blood glucose meters for use with critically ill patients. Data Sources: Recent guidance from the U.S. Food and Drug Administration and Centers for Medicare and Medicaid Services along with several recent publications will be used as the primary data sources. Data Extraction: U.S. Food and Drug Administration, Centers for Medicare and Medicaid Services communications combined with recent interpretation of this guidance were used to provide this overview. Data Synthesis: Centers for Medicare and Medicaid Services have issued a temporary moratorium on the prohibition of the use of blood glucose meters in the critically ill. They have not given a deadline for the moratorium or solicited comments. Conclusions: Physicians who care for critically ill patients need to be cognizant of the accuracy and interference limitations of blood glucose meters and aware of the current regulatory situation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据